Skip to main content

Proceeding contribution from Bob Spink (Conservative) in the House of Commons on Tuesday, 25 July 2006. It occurred during Adjournment debate on Adjournment (Summer Recess).


Adjournment (Summer Recess)

Under previous Governments no one in clinical need would be refused treatment by the NHS. But the new NHS denies treatments to sufferers from Alzheimer’s disease, and it denies anti-TNF treatments to those suffering from rheumatoid arthritis and ankylosing spondylitis. This rationed NHS is becoming less humane. Depriving brain tumour patients of drugs that can prolong their lives condemns people to a premature death. I declare an interest as my son is a neurosurgeon. That we have come so far from an NHS based on clinical judgment is evidenced by the 36 neuro-oncologists who wrote to the Secretary of State for Health to ask that two treatments—temozolomide and carmustine implants—be made available to all brain tumour patients who need them. It may be time to ensure that the methodologies of the National Institute for Health and Clinical Excellence are based on scientific evidence and that NICE takes into account the wider economic, societal and human costs or benefits when making its decisions. Why do other countries achieve palpably better outcomes on health and associated matters? For instance, buphenorphine stops morphine being taken up by the cell receptors and helps addicts come off drugs. It is used in France, where they achieve a retention rate of 88 per cent., with only a 7 per cent. delinquent rate on follow-up. But in the UK, only 28 per cent. of drug treatment and testing orders are completed satisfactorily and reconviction rates are 80 per cent., opposite figures to those achieved in France. Why are survival rates in the UK for brain cancers so low, compared with other parts of Europe? How has Australia managed to identify 80 per cent. of its chronic hepatitis C cases, compared with only 23 per cent. in the UK? I am sure that many excellent colleagues from all sides of the House will join me in pushing the Government to review their policies on NICE. In addition, I ask the Government to remove the uncertainty over Remploy, which is causing great concern. Although I understand that the Southend branch that employs so many of my constituents is not at risk, I hope that Ministers will make a statement—over the recess, if necessary—so that the minds of vulnerable people can be put at rest. We must welcome the trilateral talks on Gibraltar and its constitutional reform, to which Gibraltar’s First Minister Peter Caruana has adopted a very positive approach. In addition, we must praise and thank Cyprus for its contribution to the international effort on the evacuation of people from Lebanon. The UK must support both communities in Cyprus in the work to get a just settlement through the UN process agreed by Tassos Papadopoulos and Mehmet Ali Talat. That process should begin immediately and involve bi-communal discussions of all the issues. The UK must support and help Turkey in every way in its bid to join the EU, as it is probable that that will be one of the catalysts to the achievement of a solution to the Cyprus problem. Finally, I always hoped that the UK would be able to retain its sovereignty in the EU and bring about root-and-branch reform from within, but I now accept that Sir Teddy Taylor was right all along and that I was wrong. Our rebate and national sovereignty are under threat, as waste and corruption increase in the EU as a result of the increasing failure of accounts and controls. Nowadays, two thirds of our laws are made in Europe and not in this Parliament, but there is no proper scrutiny or democratic accountability. Therefore, I now accept that the best—the only—way forward for the UK is to withdraw from the EU. That would enable us to protect our borders better, and to generate more jobs and wealth. We would then be able to take better care of our citizens, especially those vulnerable people who, like the Remploy employees, are deeply worried about their jobs.


Secondary information

Type
Proceeding contribution
Reference
449 c826-8 
Session
2005-06
Chamber / Committee
House of Commons chamber
Subjects
Health services Drugs Gibraltar NHS
Link
View this Proceeding contribution on www.publications.parliament.uk